Stem Cell Educator Therapy in Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03390231
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03390231
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03390231. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-27 (actual); primary completion 2020-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stem Cell Educator Therapy in Diabetes
- Condition
- Diabetes Mellitus, Type 1
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Combination product)
- Stem Cell Educator therapy
- Lead sponsor
- Throne Biotechnologies Inc.
- Collaborator
- Chinese PLA General Hospital
Record details
- Record id
cardio:ct-nct03390231- Content hash
e82d496bb6da85e6852b5b83219161f0470fc9d501156413b8198550c34791c6